The joint endocrinologist + gynaecologist team that treats the whole picture — not just one side of it.
Low oestrogen is simultaneously a metabolic condition and a reproductive condition. At Gini, Dr. Anil Bhansali (Endocrinologist, former PGIMER Head, 400+ publications) and Dr. Deepika Gupta (Gynaecologist) work together — treating bone loss, cardiovascular risk, and symptoms alongside the reproductive picture. Modern HRT is safe, effective, and available at Gini.
📍 Sector 69, Mohali · Gini Advanced Care Hospital · Free Parking
Low oestrogen is not a single-specialty condition — and treating it as one produces incomplete results.
Most hormonal conditions in women are treated by either a gynaecologist or an endocrinologist — rarely both together. At Gini, Dr. Deepika Gupta (Gynaecologist) and Dr. Anil Bhansali (Endocrinologist, former PGIMER Head of Endocrinology) work as a joint team.
This matters because low oestrogen is simultaneously a metabolic and a reproductive condition. Falling oestrogen accelerates bone loss (endocrinology), increases cardiovascular risk (endocrinology), and drives symptoms like hot flushes, vaginal dryness, and bladder changes (gynaecology). Treating only one side produces incomplete results. At Gini, both sides are addressed in a single clinical team.
Oestrogen is not just a reproductive hormone. Its decline affects every major organ system in the body.
Oestrogen is the primary regulator of bone density in women. The drop at menopause accelerates bone loss by 3–5% per year in the early years — dramatically increasing osteoporosis and fracture risk without treatment.
Pre-menopausal women have significantly lower cardiovascular disease risk than men of the same age — oestrogen is protective. After menopause, women's cardiovascular risk rapidly approaches and eventually exceeds men's.
Oestrogen influences serotonin and dopamine pathways. The brain fog, concentration difficulties, mood changes, and sleep disruption of menopause are direct neurological effects of oestrogen withdrawal — not psychological weakness.
The vagina, urethra, and bladder are richly supplied with oestrogen receptors. Oestrogen deficiency causes genitourinary syndrome of menopause (GSM) — vaginal dryness, discomfort, recurrent UTIs, and urinary urgency.
Oestrogen stimulates collagen production. Its decline causes skin thinning, dryness, and accelerated ageing. Hair thinning at menopause is driven by the same hormonal mechanism.
Oestrogen has anti-inflammatory properties. Joint pain worsening at menopause — particularly in fingers, knees, and hips — is partly driven by oestrogen's protective anti-inflammatory effect being lost.
Different causes of oestrogen deficiency require different approaches. At Gini, the cause is identified first.
Average age 51 in India. Oestrogen declines gradually through perimenopause over several years. The transition produces irregular cycles, hot flushes, sleep disruption, and mood changes as oestrogen fluctuates before falling permanently.
The 40s: erratic oestrogen fluctuations — sometimes high, sometimes low. Irregular cycles, hot flushes, sleep problems, and mood changes. Often dismissed as "stress." Perimenopause is a distinct hormonal state that benefits from clinical management.
Post-hysterectomy (especially with oophorectomy): oestrogen drops immediately — the most abrupt form and often the most symptomatic. Requires prompt HRT assessment. Untreated surgical menopause carries the highest bone and cardiovascular risk.
Ovarian failure before age 40. Not optional to treat — without oestrogen, accelerated bone loss and cardiovascular risk begin decades before they would in natural menopause. POI requires urgent hormonal treatment, not watchful waiting.
These symptoms are often normalised, dismissed, or misattributed — when they have a clear hormonal cause and effective treatment.
Evidence-based HRT — form, dose, and duration selected based on individual risk profile, symptom burden, and preferences.
Convenient once-daily tablet. First-pass liver metabolism can slightly raise clotting risk — preferred when starting, but transdermal is often a better long-term choice. Combined oestrogen + progesterone (women with uterus) or oestrogen-only (post-hysterectomy).
Bypasses liver — preferred for women with cardiovascular risk factors, migraine, or gallstone history. Produces stable physiological oestrogen levels. Patches twice weekly; gels daily. Considered the safest route for most women.
For genitourinary syndrome of menopause (GSM) — vaginal dryness, recurrent UTIs, discomfort. Minimal systemic absorption. Can be used even when systemic HRT is not suitable. Does not require progesterone addition.
Body-identical progesterone — preferred over synthetic progestogens (like medroxyprogesterone). Better sleep, no increased breast cancer risk in observational data, superior cardiovascular profile. Gini's first-choice progesterone when combined HRT is indicated.
There is no evidence-based "5-year rule" for modern HRT. Treat as long as benefits exceed risks — reassessed annually. Many women continue HRT into their 60s with benefit for bone, cardiovascular, and quality of life outcomes.
The old fears about HRT came from the 2002 Women's Health Initiative (WHI) study, which used older oral preparations — conjugated equine oestrogen combined with medroxyprogesterone acetate (a synthetic progestogen). That study was stopped early and its findings were widely misinterpreted.
Modern HRT — especially transdermal oestradiol combined with micronised progesterone — has a very different safety profile. Observational studies show no increased breast cancer risk, lower clot risk than oral preparations, and strong evidence for cardiovascular and bone protection when started in the window of opportunity (within 10 years of menopause or before 60).
Dr. Bhansali and Dr. Deepika Gupta prescribe based on current evidence from the British Menopause Society, Endocrine Society, and NAMS (North American Menopause Society) — not the fears of 2002.
For women who cannot or do not want HRT — evidence-based alternatives for managing symptoms and protecting long-term health.
Common questions about oestrogen, HRT, and menopause treatment at Gini Hospital.
You don't have to accept hot flushes, bone loss, and brain fog as inevitable. Modern HRT is safe, effective, and available at Gini. Dr. Bhansali and Dr. Deepika Gupta will assess your full picture and prescribe based on current evidence. Mon–Sat, 10 AM–6 PM.